Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Nat Med. 2020 Jun;26(6):983. doi: 10.1038/s41591-020-0923-3.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

  • Published Erratum